Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial
Open Access
- 1 June 2011
- journal article
- research article
- Published by Wiley in European Journal of Heart Failure
- Vol. 13 (6), 670-680
- https://doi.org/10.1093/eurjhf/hfr020
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trialThe Lancet, 2010
- 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in AdultsCirculation, 2009
- Evaluation of the management of heart failure in primary careFamily Practice, 2009
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)European Heart Journal, 2008
- Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: Data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trialAmerican Heart Journal, 2007
- The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMETEuropean Heart Journal, 2006
- Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart FailureCirculation, 2002
- ??-Blockade in Heart FailureAmerican Journal of Cardiovascular Drugs, 2001
- HEART FAILURE: Epidemiology, aetiology, and prognosis of heart failureHeart, 2000
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999